Skip to main content
. Author manuscript; available in PMC: 2024 Feb 22.
Published in final edited form as: Auton Neurosci. 2023 Dec 6;251:103136. doi: 10.1016/j.autneu.2023.103136

Fig. 4.

Fig. 4.

Graphical representation of the influence of beta-2 adrenergic receptor agonists on loss of skeletal and cardiac muscle during cancer cachexia. Stimulation of beta-2 adrenergic receptor on both skeletal and cardiac muscle leads to increased protein synthesis and decreased protein degradation, which attenuates loss of lean mass in patients with cancer cachexia.